Skip to main content
Veterinary Medicines

Spectam Scour-Halt 50 mg/ml Drank

Not authorised
  • Spectinomycin dihydrochloride pentahydrate

Product identification

Medicine name:
Spectam Scour-Halt 50 mg/ml Drank
Spectam Scour-Halt 50 mg/ml Solution buvable
Spectam Scour-Halt 50 mg/ml Lösung zum Einnehmen
Active substance:
  • Spectinomycin dihydrochloride pentahydrate
Target species:
  • Pig (piglet)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Spectinomycin dihydrochloride pentahydrate
    74.52
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Pig (piglet)
      • Meat and offal
        12
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01XX04
Authorisation status:
  • Surrendered
Authorised in:
  • Belgium
Package description:
  • Spectam Scour-Halt 1 Bottle with 100 ml of Oral solution

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V105217
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 30/03/2022
French (PDF)
Published on: 30/03/2022
German (PDF)
Published on: 30/03/2022

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 30/03/2022
French (PDF)
Published on: 30/03/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."